TRANS-6A-ALPHA-12-ALPHA-PROPYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
Compound with spectra: 1 NMR
![TRANS-6A-ALPHA-12-ALPHA-PROPYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE](/api/compound/lTUnfn2tDx.png?ph=true&h=300&w=458 "TRANS-6A-ALPHA-12-ALPHA-PROPYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE")
| SpectraBase Compound ID | lTUnfn2tDx |
|---|---|
| InChI | InChI=1S/C17H27N3/c1-2-7-15-12-8-3-4-9-13(12)18-17-19-14-10-5-6-11-16(14)20(15)17/h14-16H,2-11H2,1H3,(H,18,19)/t14-,15+,16-/m0/s1 |
| InChIKey | ZJKYOVFXXCGSSX-XHSDSOJGSA-N |
| Mol Weight | 273.42 g/mol |
| Molecular Formula | C17H27N3 |
| Exact Mass | 273.220498 g/mol |
| Enantiomer InChIKey | ZJKYOVFXXCGSSX-OWCLPIDISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,2-Dihydro-3-cyano-4-(4-hydroxy-3-methoxyphenyl)-2-oxo-6-(10H-phenothiazin-2-yl)pyridine
9-[(2S,4R)-6-chloranyl-2-[(E)-2-phenylethenyl]-1,2,3,4-tetrahydroquinolin-4-yl]carbazole
9-[(2S,4S)-6-chloranyl-2-[(E)-2-phenylethenyl]-1,2,3,4-tetrahydroquinolin-4-yl]carbazole
5-(4-Chloro-benzoyl)-4-hydroxy-2-phenyl-4-piperidin-1-yl-2,4-dihydro-pyrazol-3-one
COMPONENT-#A-15
N-(4-Methoxyphenyl)-3,7-diphenyl-4,8-di(trifluoromethyl)-2,6-Imino-2H,6H-1,5-dithiocine
Pyrazolo[1,5-a]pyrimidine, 5-(4-fluorophenyl)-3-[(4-tricyclo[3.3.1.1(3,7)]dec-1-yl-1-piperazinyl)carbonyl]-7-(trifluoromethyl)-
1,5-Diphenyl-3-(.alpha.,N-diphenyl-carbamoyl-propylidene)pyrrol-2-one
(+)-8-HYDROXY-2-(1'-HYDROXY-1'-METHYLETHYL)-5-METHYL-2,3-DIHYDROFURO-[3,2-C]-QUINOLIN-4(5H)-ONE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Structure Elucidation of Pyrimidobenzimidazoles and Fused Derivatives II [1]. Dodecahydrobenzimidazo-[2,1-b]quinazolines and Decahydrobenzimidazo-[2,1-b]benzo[h]quinazolines [2] | Monatshefte für Chemie/Chemical Monthly | 2000 |